Delivery systems designed to have triggered release after passively targeting the tumor may improve small molecule chemotherapeutic delivery. Particle replication in nonwetting templates was used to prepare nanoparticles to passively target solid tumors in an A549 subcutaneous xenograft model. An acid labile prodrug was delivered to minimize systemic free docetaxel concentrations and improve tolerability without compromising efficacy
The complexity of tumor biology warrants tailored drug delivery for overcoming the major challenges ...
Combining molecularly targeted agents and chemotherapeutics is an emerging strategy in cancer treatm...
Purpose: Combining molecular therapies with chemotherapy may offer an improved clinical outcome for ...
Delivery systems designed to have triggered release after passively targeting the tumor may improve ...
Delivery systems designed to have triggered release after passively targeting the tumor may improve ...
Particle Replication in Nonwetting Templates (PRINT®) PLGA nanoparticles of docetaxel and acid-labil...
Nanomedicines currently approved for oncology improve certain properties of the reformulated small m...
The particle fabrication technique PRINT® was used to fabricate monodisperse size and shape specific...
Nanoparticle (NP) drug loading is one of the key defining characteristics of a NP formulation. Howev...
Novel treatment strategies, including nanomedicine, are needed for improving management of triple-ne...
<p>Breast cancer leads to high mortality of women in the world. Docetaxel (DTX) has been widely appl...
Asymmetric bifunctional silyl ether (ABS) prodrugs of chemotherapeutics were synthesized and incorpo...
We describe the development and clinical translation of a targeted polymeric nanoparticle (TNP) cont...
Jinhyang Choi,1,2 Eunjung Ko,1 Hye-Kyung Chung,3 Jae Hee Lee,1 Eun Jin Ju,1 Hyun Kyung Lim,4 Intae P...
Herein we report the fabrication of engineered poly(lactic acid-co-glycolic acid) nanoparticles via ...
The complexity of tumor biology warrants tailored drug delivery for overcoming the major challenges ...
Combining molecularly targeted agents and chemotherapeutics is an emerging strategy in cancer treatm...
Purpose: Combining molecular therapies with chemotherapy may offer an improved clinical outcome for ...
Delivery systems designed to have triggered release after passively targeting the tumor may improve ...
Delivery systems designed to have triggered release after passively targeting the tumor may improve ...
Particle Replication in Nonwetting Templates (PRINT®) PLGA nanoparticles of docetaxel and acid-labil...
Nanomedicines currently approved for oncology improve certain properties of the reformulated small m...
The particle fabrication technique PRINT® was used to fabricate monodisperse size and shape specific...
Nanoparticle (NP) drug loading is one of the key defining characteristics of a NP formulation. Howev...
Novel treatment strategies, including nanomedicine, are needed for improving management of triple-ne...
<p>Breast cancer leads to high mortality of women in the world. Docetaxel (DTX) has been widely appl...
Asymmetric bifunctional silyl ether (ABS) prodrugs of chemotherapeutics were synthesized and incorpo...
We describe the development and clinical translation of a targeted polymeric nanoparticle (TNP) cont...
Jinhyang Choi,1,2 Eunjung Ko,1 Hye-Kyung Chung,3 Jae Hee Lee,1 Eun Jin Ju,1 Hyun Kyung Lim,4 Intae P...
Herein we report the fabrication of engineered poly(lactic acid-co-glycolic acid) nanoparticles via ...
The complexity of tumor biology warrants tailored drug delivery for overcoming the major challenges ...
Combining molecularly targeted agents and chemotherapeutics is an emerging strategy in cancer treatm...
Purpose: Combining molecular therapies with chemotherapy may offer an improved clinical outcome for ...